Cargando…

Effects of alirocumab on types of myocardial infarction: insights from the ODYSSEY OUTCOMES trial

AIMS : The third Universal Definition of Myocardial Infarction (MI) Task Force classified MIs into five types: Type 1, spontaneous; Type 2, related to oxygen supply/demand imbalance; Type 3, fatal without ascertainment of cardiac biomarkers; Type 4, related to percutaneous coronary intervention; and...

Descripción completa

Detalles Bibliográficos
Autores principales:	White, Harvey D, Steg, Ph Gabriel, Szarek, Michael, Bhatt, Deepak L, Bittner, Vera A, Diaz, Rafael, Edelberg, Jay M, Erglis, Andrejs, Goodman, Shaun G, Hanotin, Corinne, Harrington, Robert A, Jukema, J Wouter, Lopes, Renato D, Mahaffey, Kenneth W, Moryusef, Angele, Pordy, Robert, Roe, Matthew T, Sritara, Piyamitr, Tricoci, Pierluigi, Zeiher, Andreas M, Schwartz, Gregory G
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2019
Materias:	Fast Track Clinical Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6736383/ https://www.ncbi.nlm.nih.gov/pubmed/31121022 http://dx.doi.org/10.1093/eurheartj/ehz299

Ejemplares similares

Effect of alirocumab on cardiovascular outcomes after acute coronary syndromes according to age: an ODYSSEY OUTCOMES trial analysis
por: Sinnaeve, Peter R, et al.
Publicado: (2020)

Effect of Alirocumab on Mortality After Acute Coronary Syndromes: An Analysis of the ODYSSEY OUTCOMES Randomized Clinical Trial
por: Steg, Philippe Gabriel, et al.
Publicado: (2019)

Transiently achieved very low low-density lipoprotein cholesterol levels by statin and alirocumab after acute coronary syndrome are associated with cardiovascular risk reduction: the ODYSSEY OUTCOMES trial
por: Schwartz, Gregory G, et al.
Publicado: (2023)

Effect of Alirocumab on Stroke in ODYSSEY OUTCOMES
por: Jukema, J. Wouter, et al.
Publicado: (2019)

Effect of alirocumab on major adverse cardiovascular events according to renal function in patients with a recent acute coronary syndrome: prespecified analysis from the ODYSSEY OUTCOMES randomized clinical trial
por: Tuñón, José, et al.
Publicado: (2020)

Lipoprotein(a) lowering by alirocumab reduces the total burden of cardiovascular events independent of low-density lipoprotein cholesterol lowering: ODYSSEY OUTCOMES trial
por: Szarek, Michael, et al.
Publicado: (2020)

Peripheral Artery Disease and Venous Thromboembolic Events After Acute Coronary Syndrome: Role of Lipoprotein(a) and Modification by Alirocumab: Prespecified Analysis of the ODYSSEY OUTCOMES Randomized Clinical Trial
por: Schwartz, Gregory G., et al.
Publicado: (2020)

Effect of alirocumab on cataracts in patients with acute coronary syndromes
por: Suc, Gaspard, et al.
Publicado: (2023)

Correction: Effect of alirocumab on cataracts in patients with acute coronary syndromes
por: Suc, Gaspard, et al.
Publicado: (2023)

Clinical Efficacy and Safety of Alirocumab After Acute Coronary Syndrome According to Achieved Level of Low-Density Lipoprotein Cholesterol: A Propensity Score–Matched Analysis of the ODYSSEY OUTCOMES Trial
por: Schwartz, Gregory G., et al.
Publicado: (2021)

Alirocumab after acute coronary syndrome in patients with a history of heart failure
por: White, Harvey D, et al.
Publicado: (2021)

Relation of Lipoprotein(a) Levels to Incident Type 2 Diabetes and Modification by Alirocumab Treatment
por: Schwartz, Gregory G., et al.
Publicado: (2021)

Long‐Term Efficacy, Safety, and Tolerability of Alirocumab in 8242 Patients Eligible for 3 to 5 Years of Placebo‐Controlled Observation in the ODYSSEY OUTCOMES Trial
por: Goodman, Shaun G., et al.
Publicado: (2023)

Pharmacogenetics-guided dalcetrapib therapy after an acute coronary syndrome: the dal-GenE trial( )
por: Tardif, Jean Claude, et al.
Publicado: (2022)

Antibiotic Cycling and Antibiotic Mixing: Which One Best Mitigates Antibiotic Resistance?
por: Beardmore, Robert Eric, et al.
Publicado: (2017)

Physicochemical properties of SARS‐CoV‐2 for drug targeting, virus inactivation and attenuation, vaccine formulation and quality control
por: Scheller, Christin, et al.
Publicado: (2020)

Inferring Population Histories for Ancient Genomes Using Genome-Wide Genealogies
por: Speidel, Leo, et al.
Publicado: (2021)

BUSCO Applications from Quality Assessments to Gene Prediction and Phylogenomics
por: Waterhouse, Robert M, et al.
Publicado: (2018)

Neuroprotective maraviroc monotherapy in simian immunodeficiency virus-infected macaques: reduced replicating and latent SIV in the brain
por: Kelly, Kathleen M., et al.
Publicado: (2013)

Patiromer for the management of hyperkalemia in heart failure with reduced ejection fraction: the DIAMOND trial( )
por: Butler, Javed, et al.
Publicado: (2022)

Anisotropic Isolation by Distance: The Main Orientations of Human Genetic Differentiation
por: Jay, Flora, et al.
Publicado: (2013)

Good Codons, Bad Transcript: Large Reductions in Gene Expression and Fitness Arising from Synonymous Mutations in a Key Enzyme
por: Agashe, Deepa, et al.
Publicado: (2013)

The Adaptation of Temperate Bacteriophages to Their Host Genomes
por: Bobay, Louis-Marie, et al.
Publicado: (2013)

MAFFT Multiple Sequence Alignment Software Version 7: Improvements in Performance and Usability
por: Katoh, Kazutaka, et al.
Publicado: (2013)

At the Transition from Invertebrates to Vertebrates, a Novel GnRH-Like Peptide Emerges in Amphioxus
por: Roch, Graeme J., et al.
Publicado: (2014)

Possible Loss of the Chloroplast Genome in the Parasitic Flowering Plant Rafflesia lagascae (Rafflesiaceae)
por: Molina, Jeanmaire, et al.
Publicado: (2014)

RetrogeneDB—A Database of Animal Retrogenes
por: Kabza, Michał, et al.
Publicado: (2014)

Patterns of Positive Selection in Seven Ant Genomes
por: Roux, Julien, et al.
Publicado: (2014)

An Experimentally Determined Evolutionary Model Dramatically Improves Phylogenetic Fit
por: Bloom, Jesse D.
Publicado: (2014)

Bears in a Forest of Gene Trees: Phylogenetic Inference Is Complicated by Incomplete Lineage Sorting and Gene Flow
por: Kutschera, Verena E., et al.
Publicado: (2014)

ExaBayes: Massively Parallel Bayesian Tree Inference for the Whole-Genome Era
por: Aberer, Andre J., et al.
Publicado: (2014)

Parallel Evolution of Tetrodotoxin Resistance in Three Voltage-Gated Sodium Channel Genes in the Garter Snake Thamnophis sirtalis
por: McGlothlin, Joel W., et al.
Publicado: (2014)

CodonPhyML: Fast Maximum Likelihood Phylogeny Estimation under Codon Substitution Models
por: Gil, Manuel, et al.
Publicado: (2013)

Comparative Genome Analysis and Gene Finding in Candida Species Using CGOB
por: Maguire, Sarah L., et al.
Publicado: (2013)

Insights into the Origin of Metazoan Filopodia and Microvilli
por: Sebé-Pedrós, Arnau, et al.
Publicado: (2013)

Linking Great Apes Genome Evolution across Time Scales Using Polymorphism-Aware Phylogenetic Models
por: De Maio, Nicola, et al.
Publicado: (2013)

Using an Epidemiological Model for Phylogenetic Inference Reveals Density Dependence in HIV Transmission
por: Leventhal, Gabriel E., et al.
Publicado: (2014)

Strong Heterogeneity in Mutation Rate Causes Misleading Hallmarks of Natural Selection on Indel Mutations in the Human Genome
por: Kvikstad, Erika M., et al.
Publicado: (2014)

The First Venomous Crustacean Revealed by Transcriptomics and Functional Morphology: Remipede Venom Glands Express a Unique Toxin Cocktail Dominated by Enzymes and a Neurotoxin
por: von Reumont, Björn M., et al.
Publicado: (2014)

Reconciling Phylodynamics with Epidemiology: The Case of Dengue Virus in Southern Vietnam
por: Rasmussen, David A., et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_od9rgbm69cnq7i0eoi2qpm4kps